SERP1 and pancreatic neoplasm: These studies suggest that blockade of the thrombolytic serine protease pathways with either Serp-1 or NSP effectively blocks pancreatic cancer cell growth in vivo in SCID mice while blockade of the chemokine pathways was not effective in reducing tumor growth.